Cargando…
Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery
Machine learning is a well-known approach for virtual screening. Recently, deep learning, a machine learning algorithm in artificial neural networks, has been applied to the advancement of precision medicine and drug discovery. In this study, we performed comparative studies between deep neural netw...
Autores principales: | Tsou, Lun K., Yeh, Shiu-Hwa, Ueng, Shau-Hua, Chang, Chun-Ping, Song, Jen-Shin, Wu, Mine-Hsine, Chang, Hsiao-Fu, Chen, Sheng-Ren, Shih, Chuan, Chen, Chiung-Tong, Ke, Yi-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545175/ https://www.ncbi.nlm.nih.gov/pubmed/33033310 http://dx.doi.org/10.1038/s41598-020-73681-1 |
Ejemplares similares
-
Discovery and Synthesis
of a Pyrimidine-Based Aurora
Kinase Inhibitor to Reduce Levels of MYC Oncoproteins
por: Chi, Ya-Hui, et al.
Publicado: (2021) -
Tools for GPCR drug discovery
por: Zhang, Ru, et al.
Publicado: (2012) -
Discovery of Pathologic GPCR Aggregation
por: Quitterer, Ursula, et al.
Publicado: (2019) -
Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
por: Colom, Matthieu, et al.
Publicado: (2019) -
Class B1 GPCR activation by an intracellular agonist
por: Kobayashi, Kazuhiro, et al.
Publicado: (2023)